Berberine Cut Visceral Fat by 23% in a JAMA-Published Trial
Most weight loss supplements don't survive peer review. Berberine just did — in JAMA, no less.
A randomized, double-blind trial published in JAMA Network Open found that berberine supplementation reduced visceral fat area by 23% over 12 weeks compared to placebo. The study enrolled participants with central obesity and tracked changes via CT imaging — not just scale weight, but the dangerous fat that wraps around your organs.
Why visceral fat matters more than the number on your scale
You can be "thin" and still carry visceral fat. This type of fat is metabolically active — it secretes inflammatory cytokines, messes with insulin signaling, and correlates strongly with cardiovascular disease risk. Losing visceral fat specifically is far more meaningful than losing total body weight.
What the study actually found
- 23% reduction in visceral fat area (measured by CT scan) - Improved fasting glucose and insulin sensitivity markers - Dose: 500mg berberine, 3 times daily with meals - Duration: 12 weeks - Side effects: Mild GI discomfort in some participants (common with berberine)
The important detail: this wasn't a fringe journal. JAMA Network Open has rigorous peer review standards. The study design (randomized, double-blind, placebo-controlled) is the gold standard.
The catch
Berberine interacts with several common medications, particularly metformin (both lower blood sugar — combining them risks hypoglycemia) and statins (berberine affects the same liver enzymes). If you're on prescription medication, checking for interactions isn't optional — it's essential.
We built a free herb-drug interaction checker that covers berberine and 150+ other medicinal plants against 200+ medications. You can check specific combinations before making decisions.
The bigger picture
Berberine is one of the most evidence-backed plant compounds for metabolic health. The JAMA trial adds to an already substantial body of research. But "evidence-backed" doesn't mean "take without thinking" — context, dose, and drug interactions all matter.
For the full study breakdown with methodology details and clinical context, read our detailed analysis.
---
Botanica Andina covers medicinal plant research with a focus on evidence-based analysis and clinical context.